title: Alpha IIb beta 3 integrin expression and function in subpopulations of murine tumors.
abstract: Subpopulations of B16 amelanotic melanoma (B16a) cells, isolated by centrifugal elutriation from enzymatically dispersed solid tumors, demonstrated different abilities to form lung colonies when injected intravenously. In contrast, no differences in experimental metastasis were observed among subpopulations obtained from Lewis lung (3LL) tumors. Lung colonization by B16a and 3LL subpopulations correlated positively with observed differences (B16a) or lack of differences (3LL) in tumor cell ability to induce aggregation of homologous platelets, to adhere to subendothelial matrix or fibronectin, and with the percentage of cells in the G2/M phase of the cell cycle. Both B16a and 3LL cells express alpha IIb beta 3 integrin receptors; however, differences in the receptor expression level were found only among B16a subpopulations. Comparison of the amount of alpha IIb beta 3 receptor expressed on cell surface with tumor cell ability to induce platelet aggregation (TCIPA) and to adhere to fibronectin or subendothelial matrix revealed a positive correlation. Pretreatment of tumor cells with alpha IIb beta 3-specific antibodies inhibited tumor cell matrix adhesion, TCIPA, and lung colony formation. We propose that alpha IIb beta 3 integrin receptor expression, tumor cell matrix adhesion, and tumor cell-induced platelet aggregation can be important parameters to indicate the metastatic potential of some tumor cells and that the alpha IIb beta 3 is a multifunctional receptor involved in both tumor cell-matrix and tumor cell-platelet interactions. Further, the correlation among cell cycle phase, metastatic ability, and receptor expression suggests that metastatic propensity may be transiently expressed and/or increased in some tumor cell subpopulations.
authors.affiliation: Department of Radiation Oncology, Wayne State University, Detroit, Michigan 48202.
authors.forename: K V
authors.initials: KV
authors.lastname: Honn
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Chen
authors.forename: J
authors.initials: J
authors.lastname: Timar
authors.forename: J M
authors.initials: JM
authors.lastname: Onoda
authors.forename: J S
authors.initials: JS
authors.lastname: Hatfield
authors.forename: S E
authors.initials: SE
authors.lastname: Fligiel
authors.forename: B W
authors.initials: BW
authors.lastname: Steinert
authors.forename: C A
authors.initials: CA
authors.lastname: Diglio
authors.forename: I M
authors.initials: IM
authors.lastname: Grossi
authors.forename: K K
authors.initials: KK
authors.lastname: Nelson
mesh_terms: D000818:Animals; D015870:Gene Expression; D016023:Integrins / Q000096:biosynthesis* / Q000276:immunology / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000503:physiopathology; D010974:Platelet Aggregation; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014407:Tumor Cells, Cultured / Q000378:metabolism*
chemical_list: D016023:Integrins; D019039:Platelet Glycoprotein GPIIb-IIIa Complex